1. Background {#sec0005}
=============

Most respiratory tract infections are caused by viruses or bacteria with viruses causing the highest proportion of infections. The major causes of acute respiratory infections (ARI) in children are respiratory syncytial virus (RSV), parainfluenzavirus (PIV), influenza virus (IFV), adenovirus (AdV), and human rhinoviruses (HRV). Human metapneumovirus (HMPV), human coronaviruses (HCoV) HKU1, NL63, 229E and OC43, PIV4, human enterovirus (HEV) ([@bib0045]), human bocavirus (HBoV), parvovirus type 4 and 5, and mimivirus have recently been implicated as etiological agents of acute lower respiratory tract infections (ALRTIs) albeit at a lower frequency ([@bib0025]; [@bib0140]; [@bib0190]). Laboratory confirmation is required to identify aetiological agents of respiratory virus infections since viral agents cannot be differentiated on clinical features alone ([@bib0140]). Sensitive and rapid diagnosis of respiratory infections in hospitalized children is cost-effective. It is pivotal in directing active treatment early in the course of the illness following detection, reducing unnecessary antibiotic prescription, and limiting nosocomial transmission to high-risk patients ([@bib0005]; [@bib0150]; [@bib0215]; [@bib0305]). In addition, assessment of the morbidity of specific etiological agents of ALRTIs identified using sensitive detection methods in hospitalized patients is important to determine agent-specific interventions such as vaccination against RSV ([@bib0150]). Extensive detection of infections will also expand our knowledge of the etiology of pneumonia and assist in determining which etiological agents should be considered for vaccine development ([@bib0250]). Recent developments in molecular diagnosis of respiratory viruses and the discovery of new viruses have renewed the interest in respiratory virus epidemiology. However, there is still a considerable deficiency in the diagnosis of viruses which cause ALRTI ([@bib0115]). Far too little attention has been paid to the epidemiology of respiratory viral infections in Malaysia. Therefore, in this study, the goal was to detect a panel of classical and newly discovered respiratory viruses including IFV, RSV, PIV, AdV, HMPV, HRV, HEV, HCoV, and HBoV which cause ALRTI in children below 5 years of age at Hospital Serdang. Both conventional methods including direct immunofluorescence assay, cell culture and shell vial culture and molecular diagnostic techniques including multiplex PCR and sequencing were used.

2. Materials and methods {#sec0010}
========================

2.1. Study design {#sec0015}
-----------------

The survey was conducted at two 28-bed pediatric wards in Hospital Serdang, a government-funded multi-specialty hospital located in the district of Sepang in the state of Selangor, Malaysia. The participants were children more than one-month-old and less than 5 years of age who were admitted to the hospital between June 16, and December 21, 2009 with the diagnosis of ALRTI. Patients with congenital or acquired immunosuppressive conditions, with conditions that posed a potential hazard in obtaining the nasopharyngeal samples (e.g. bleeding diathesis, severe respiratory compromise) as determined by the clinicians and children with incomplete data or inadequate samples were excluded from the study. All potential subjects (including careers of the patients) were briefed on the study before written informed consent was obtained by the pediatrician in-charge of the case. Approval from the following authorities was obtained prior to the start of the study: the Ministry of Heath Malaysia Research and Ethics Committee (MREC) (NMRR-09-161-638), the Medical Research Ethics Committee, Faculty of Medicine and Health Sciences, UPM (UPM/FPSK/PADS/T7-MJKEtikaPer/F01 (JMPP FEP (9) 32)) and the Research Ethics Board of Hospital Serdang were obtained. Blood samples for bacterial culture were collected by the nurses involved in the study and sent to the Department of Pathology, Hospital Serdang.

2.2. Specimen processing {#sec0020}
------------------------

Nasopharyngeal aspirate (NPA) was taken through both nostrils by inserting a disposable catheter (no. 6 or no. 8) connected to a mucus extractor. NPAs were transported in viral transport medium (VTM) to the laboratory and refrigerated at 4 °C--8 °C until required. In order to avoid repeated freezing and thawing, all NPAs were processed upon receipt. The samples were vortexed vigorously for 15 s and centrifuged at 600 ×g for 7 min. The supernatant was collected and set aside for virus isolation and genome extraction. The cell pellet was used in a direct Immunofluorescence Assay (DFA) after washing several times to remove mucus to avoid nonspecific fluorescence. Most of the samples were detected with DFA at the same day of samples received followed by cell culture and genome extraction and cDNA synthesis. The PCR reaction was performed when a bunch of samples were available. Detection of the viruses was performed concurrently during the six months of the study period.

2.3. Immunological assays {#sec0025}
-------------------------

The D3 Ultra 8 Direct Immunofluorescence Assay Respiratory Virus Screening & Identification kit (Diagnostic Hybrids Inc. (DHI), USA) which contains a blend of murine fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies (MAbs) was used as the first step to detect eight common viruses including RSV, HMPV, IFV type A and B, PIV 1-3, HAdV. DFA negative samples were inoculated onto shell vial culture (SVC). R-Mix TM Ready cells (DHI, USA), ready-to-use mixed cell monolayers comprising mink lung cells (Mv1Lu) and human Adenocarcinoma cells (A549), were used according to the manufacturer's recommendations.

2.4. Genome extraction and reverse transcription {#sec0030}
------------------------------------------------

Viral RNA/DNA was extracted from the filtered supernatant of NPA using MagMAX Viral RNA Isolation Kit (Applied Biosystems, Ambion, USA) according to the manufacturer's instructions. The concentration and purity of the extracts (A260/A280 nm and A260/A230 nm) were measured using a NanoDrop (ThermoFisher Scientific, USA). The first strand cDNA synthesis was carried out on RNA extracts in a final volume of 20 μl by random hexamer primer using RevertAid^™^ H Minus First Strand cDNA Synthesis kit (Fermentas, USA) following the manufacturer's instructions. The samples were incubated first for 5 min at 25 °C followed by 60 min at 42 °C. The reaction was terminated by heating at 70 °C for 5 min.

2.5. Polymerase chain reaction {#sec0035}
------------------------------

Three multiplex RT-PCR (MP/RT-PCR1--3) and subsequently two hemi-nested multiplex PCR assays (HNMP/PCR 1--2) were carried out for the molecular detection of RNA viruses ([@bib0035]). MP/RT-PCR1 targeted influenza viruses A and B, RSV (types A and B), HMPV (A and B). MP/RT-PCR2 detected parainfluenza virus types 1, 2, 3 and 4 (A and B) (PIV 1--4). The MP/RT-PCR 3 contained primers for the detection of HRV, HEV, HCoV OC43 and 229E. An internal control consisting of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was included in MP/RT-PCR2. HBoV and HAdV were detected in the samples by singleplex PCR and nested PCR respectively ([@bib0010]; [@bib0185]). Primer set HAdVhexF1/AdhexR1and nested primer set AdhexF2/AdhexR2 were used to detect HAdV hexon gene hyper-variable regions 1--6 (HVR1 − 6). The PCR products were separated by electrophoresis in a 2.5% agarose gel and visualized using ethidium bromide under UV light. The multiplex PCR was validated using pCR^®^2.1-TOPO^®^ plasmid vector \[TOPO TA cloning® kit (Invitrogen, USA)\].

2.6. Virus culture {#sec0040}
------------------

HEp-2 (ATCC CCL-23, USA), MRC-5 (ATCC CCL-171, USA), Vero (ATCC (CCL-81, USA) and HeLa cells (ATCC, USA) were purchased from American Type Culture Collection (ATCC) and cultured according to their guidelines. All RSV positive samples were cultured on Vero and HEp-2 cells. HAdV positive samples were inoculated onto HeLa and HEp-2 cells. MRC-5 and HeLa cells were used for samples which were positive for HRV. Cell cultures with characteristic CPE for RSV and HAdV were harvested and confirmatory testing was performed with DFA. The tube cultures showing CPE for HRV were harvested and confirmed by PCR. A second blind passage was performed after a week for cultures without characteristic CPE.

2.7. Statistical analysis {#sec0045}
-------------------------

Data were analyzed using SPSS version 16.0. All *p*-values were two-tailed and *p*-values of \< 0.05 were considered statistically significant. Comparisons between the results obtained by molecular methods and conventional methods were evaluated by McNemar's test and paired-samples t-test.

3. Results {#sec0050}
==========

3.1. Conventional methods {#sec0055}
-------------------------

A total of 165 children less than five years of age who fulfilled the inclusion criteria as outlined above and were hospitalized with ALRTIs during a 20-week period between June 16, and December 21, 2009 were enrolled in the study. DFA was the first conventional method of detection of common respiratory viruses used to identify eight viruses including IFV A & B, PIVs 1--3, RSV, HMPV and HAdV. HRV, HEV, HCoVs, PIV4 and HBoV were excluded from immunological detection because of a lack of specific monoclonal antibodies. For each virus the pattern of immunofluorescent staining was specific and was used for confirmatory purposes. Eighty eight (53.9%) of the 165 NPA samples were DFA positive as follows: 67 (40.6%) for RSV, 9 (5.5%) for HMPV, 4 (2.4%) for HAdVs, 3 (1.8%) for IFV A and 6 (3.61%) for PIVs 1-3. Detection of RSV, HMPV, PIV1--3, IFV-A & B, HAdV in shell vial culture was attempted as the second stage of the conventional method on the remaining 76 DFA negative NPA samples. Seven additional viruses were detected and a total of 95 (57.6%) samples were virus positive by DFA followed by shell-vial culture. Therefore, this method was able to detect some viruses which were missed by DFA: 4 RSV and one case each for HAdV, HMPV and PIV2. For RSV, CPE was detected in 31 of 83 specimens representing a 37% recovery. Twenty-four samples positive for HAdVs were inoculated into HeLa and HEp-2 cell lines. Five of 24 samples (21%) showed characteristic CPE. Semi-confluent monolayers of HeLa and MRC-5 cell lines were used to isolate 26 of the 54 HRV positive samples detected using RT-PCR.

3.2. Molecular methods {#sec0060}
----------------------

The ability of the multiplex method to specifically detect multiple viruses in the same reaction tube was evaluated by testing a mixture of cloned plasmids of targeted viruses. Analysis of the PCR products showed that each multiplex method simultaneously detected all three control viruses included in each reaction as well as the internal control with the expected band sizes. In the presence of all primer sets in the multiplex reaction, no mispriming was observed in the positive and negative control tubes. The specificity of the MP/RT-PCR products was confirmed by nucleotide sequence analysis. Three multiplex RT-PCR (MP/RT-PCR 1--3) and subsequently 2 hemi-nested multiplex PCR (HNMP/PCR 1--2) were carried out on nucleic acids extracted from 165 clinical specimens. The specific products were clearly separated and identified on a 2.5% Seakem agarose gel, both for virus control and for clinical specimens. In total, 154 samples (93.3%) from the panel of 165 were virus positive and 11 (6.7%) specimens were virus negative using this method. Almost all viruses (97%) were detected in the first stage of the MP/RT-PCR1-3 assay. In the second stage six (6/183, 3%) additional viruses were detected by HNMP/PCR1-2. Using normal and nested PCR, of the 165 samples tested, 6 were found to be positive for HBoV and 24 (14.5%) for adenovirus. Of these positive samples, single infections were documented in one HBoV and three cases of HAdV infection. In total, 158 samples (95.8%) were positive for respiratory viruses using the molecular method while 7 (4.2%) were negative. GAPDH was successfully amplified from all of the NPA samples tested by PCR indicating that there were no PCR inhibitors in the reactions. Therefore, false negative results were excluded using this internal control.

3.3. Multiple viral infections {#sec0065}
------------------------------

One hundred and twelve patients (67.9%) were found to be infected with a single virus with the most frequently detected viruses being RSV (30%), HRV (22%), IFV-A (6.1%) and HMPV (4.8%)([Table1](#tbl0005){ref-type="table"} ). No single infection due to HCoVs was observed. Multiple respiratory viral infections were documented in 46 (28%) samples; consisting of 37 (22.4%) double infections and 9 (5.5%) triple infections. The most frequently detected viruses in these patients were RSV (34, 73.9%), followed by HAdV (21, 45.6%) and HRV (18, 39.1%). Dual infections of RSV with HAdV and HRV were the most prevalent multiple viral infections found in the study (13/46, 28% and 11/46, 24%, respectively). Culture of blood samples from 165 patients revealed bacterial infections in only five (3%) cases including one patient with a single infection (0.6%) with ἀ-hemolytic *Streptococcus viridans*. Four other samples were also virus positive and were considered to be nosocomial infections (blood cultures results were positive after 48 h) as follows: 2 RSV/*Burkholderia cepacia*, 1 HRV/ *B. cepacia* and 1HRV/ coagulase-negative staphylococcus. *M. pneumonia* infections were not identified in any of the 165 patients.Table 1Single and Multiple Viral Infections by Viral Etiology (n = 165).Table 1PathogensTotalSingle-infectionDouble-infectionTriple-infection**RSV**83 (50.3)[a](#tblfn0005){ref-type="table-fn"}49 (29.7)29(17.6)5(3.0)**HRV**54 (32.7)36 (21.8)14(8.5)4(2.4)**HAdV**24 (14.5)3 (1.8)14 (8.5)7(4.2)**HMPV**16 (9.6)8 (4.8)5(3.0)3(1.8)**IFV-A**15 (9.1)10 (6.1)3 (1.8)2(1.2)**PIVs**8 (4.8)3 (1.8)2(1.2)3(1.8)**PIV-1**1 (0.6)001 (0.6)**PIV-2**3 (1.8)1 (0.6)1(0.6)1(0.6)**PIV-3**4 (2.4)2 (1.2)1(0.6)1(0.6)**HBoV**6 (3.6)1 (0.6)3(1.8)2(1.2)**HCoV-OC43**4 (2.4)03(1.6)1(0.6)**HEV**3 (1.8)2 (1.2)1(0.6)0[^1]

3.4. Conventional methods versus molecular methods {#sec0070}
--------------------------------------------------

In total, 158 specimens (95.8%) from the panel of 165 were virus positive by a combination of conventional and molecular methods, and seven (4.2%) specimens were virus negative. The comparison between conventional and molecular methods is depicted in [Table 2](#tbl0010){ref-type="table"} . A greater number of samples (95.8%) were found to be virus positive using molecular methods compared to conventional methods (69.1%) (p \< 0.001, McNamara's test). There were 69 (41.9%), 63 (38.2%) and 36 (21.9%) more positive samples compared with DFA, DFA plus SVC and DFA plus SVC plus conventional cell culture methods, respectively. On the other hand molecular assays were able to detect 91 more viruses (p \< 0.001, Paired-samples t-test).Table 2Comparison of Conventional and Molecular Methods.Table 2ConventionalMolecular*p*VariablesAssays^a^Assay*value*No. of detectable viruses914No. of NPA tested165165No. (%) of positive NPA114 (69.1)158 (95.8)\<0.001^d^No. of virus detected114213\<0.001^e^No. of extra virus detected092No. of samples with co-infections046 (27.9)  **No. of positive NPA by virus types1. Conventional viruses94 (56.9)146 (88.5)**RSV71 (43.0)83 (50.3)\<0.001 ^d^HMPV11 (6.7)16 (9.7)0.062 ^d^IFV-A3 (1.8)15 (9.1)\<0.001 ^d^IFV-B00--PIV11 (0.6)1 (0.6)--PIV22 (1.2)3 (1.8)--PIV31 (0.6)4 (2.4)--HAdV5 (3.0)24 (14.5)\<0.001 ^d^  **2. Unconventional viruses27 (16.4)67 (41.0)**--PIV4NA0--HRV27 (16.4)54 (32.7)\<0.001 ^d^HEVNA3 (1.8)--HCOV OC43NA4 (2.4)--HCOV 229ENA0--HBoVNA6 (3.6)--[^2]

3.5. Monthly distribution of viral infections {#sec0075}
---------------------------------------------

The monthly distribution of cases with respiratory tract viruses is shown in [Fig. 1](#fig0005){ref-type="fig"} . During the study period, a continuously persisting activity was seen for RSV, HRV, HAdV, and HMPV. Influenza A was detected from July to September, with a peak in August followed by a plateau from September onwards. An increased incidence of HRV and RSV cases was seen after the influenza. A peak from September onwards, peaking in October. For the viruses with low incidence, no distinct pattern was seen.Fig. 1Monthly Distribution of RSV, HRV, HAdV, HMPV, and IFV-A Infections.Fig. 1

4. Discussion {#sec0080}
=============

Recent developments in molecular diagnostics and the discovery of new viruses have created a renewed interest in the epidemiology of respiratory viruses. Different ensitivities of the diagnostic assays, make evaluation of the exact contribution of each virus in epidemiology difficult ([@bib0270]). Regional determination of the epidemiology of specific viral infections will improve the treatment guidelines for doctors ([@bib0120]). The main goal of the current study was to detect a broad panel of respiratory viruses associated with hospitalized children with ALRTIs in Malaysia. We report a high prevalence of respiratory viruses in hospitalized children ([@bib0020]; [@bib0125]; [@bib0130]; [@bib0235]). This was achieved using highly sensitive nested PCR which was applied to a broad spectrum of viruses. NPA samples from 158 (95.8%) patients were positive for single and/or multiple viruses. Single virus infections were detected in approximately two-thirds of the samples compared with almost one-third of samples which were found to contain multiple viruses. The performance of conventional diagnostic methods and molecular methods was also evaluated using the samples in this study. As reported in other studies ([@bib0070], [@bib0065]; [@bib0095]; [@bib0155]; [@bib0285]) we established that molecular methods were more sensitive than conventional methods for the detection of respiratory viruses in children hospitalized with ALRTIs.

Many respiratory viruses including RSV-A, and B, IFV-A, PIV1, PIV2, PIV3, HMPV, HRV-A and C, HEV, HAdV, HBoV, and HCoV-OC43 were detected in the patients in this study. RSV was the most prevalent virus detected in 50% of samples. Previous publications have frequently identified RSV as the major viral pathogen associated with LRTI in children ([@bib0050]; [@bib0100]; [@bib0110]; [@bib0235]; [@bib0310]). Our results provide further supporting evidence that RSV infection is a frequent cause of hospitalization among children in tropical and developing countries ([@bib0280]; [@bib0290]). HRV was the second most prevalent virus and was detected in one-third of patients which is a similar infection rate to that reported in other studies ([@bib0060]; [@bib0145]; [@bib0160]; [@bib0180]; [@bib0200], [@bib0195]; [@bib0220]; [@bib0230]).

RSV and HRV have also been reported as the most common causes of LRTIs in other studies ([@bib0040]; [@bib0090]; [@bib0105]; [@bib0130]; [@bib0220]). The finding of the current study is also consistent with study by Nathan who found RV and HRV as the most detected virus associated with ALRTIs in a prospective study in Malaysia ([@bib0205]). Co-infections with other viruses were found in approximately 33% (18/54) of HRV infections. The high prevalence of HRV in this study suggests that virus testing should be routinely aq

HAdV was the third (14.5%) most common virus detected in this study. Adenoviruses are responsible for 3.6--13% of all LRTIs occurring in infants and children ([@bib0055]; [@bib0130]; [@bib0135]; [@bib0170]; [@bib0240]). Our findings seem to be consistent with the detection rate of 14% among hospitalized children with ALRTIs in Argentina ([@bib0275]). This high detection rate is especially important in developing countries with high prevalence of measles and malnutrition.

HMPV was detected as the fourth most prevalent virus with an infection rate of 10%. This is consistent with a 5.3--13% detection rate among otherwise healthy children hospitalized with LRTIs in several other studies ([@bib0080]; [@bib0165]; [@bib0295]; [@bib0300]). We demonstrated for the first time that HMPV could be an important cause of LRTI in children in Malaysia. The positivity rate is also comparable with a recent study of children hospitalized with ALRTI in subtropical Brazil (11.4%) ([@bib0210]). The prevalence of HBoV was between 1.5% ([@bib0030]) to 19% ([@bib0015]) in these children with respiratory infections. In our study, HBoV was detected for the first time in Malaysia in 6 of 165 nasopharyngel aspirates giving a prevalence of 3.6% ([@bib0075]). The detection rate was comparable to that (3.4%) reported in France ([@bib0085]) and Sweden (3.1%) ([@bib0015]) but was lower than that reported (8.0%) in Singapore ([@bib0255]).

Sensitive multiplex PCR assays give useful information about the presence of multiple pathogens and their epidemiological and clinical effects ([@bib0035]). In the current study, all of the multiple infections were diagnosed exclusively using PCR, which further supports the superiority of molecular methods over conventional methods ([@bib0245]; [@bib0265]). Evaluation of the relative importance of each coexisting agent may play an important role in understanding the etiopathogenesis of these viruses ([@bib0260]). Identification of all infectious agents is especially important in high-risk immonocompromised patients for appropriate antiviral therapy ([@bib0175]). In this study, multiple viral infections were found in 28% of patients and were usually combinations of RSV with HAdV and/or HRV. The co-detection rate is similar to that found by Calvo (2010) ([@bib0040])(23%), Belau-Pujol (2005) ([@bib0035])(23%), Richard (2008) ([@bib0235])(24.4%) and van de Pol (2006) ([@bib0265])(35%). The relatively high coinfection rate in this study may be explained by the broad panel of viruses investigated. This supports the theory that HRV, HAdV, HCoV and HMPV are highly prevalent in multiple infections ([@bib0265]). It is surprising that a high diversity of virus combinations was found in the samples. This may be due in part to the continued presence of all of the surveyed viruses during the study period with no distinct seasonality. RSV and HAdV was the most commonly detected co-infection. The high proportion of HAdV co-infections (87.5%) with other viruses in this study is comparable with (89%) HAdV co-infection rates in a study by Calvo (2010)([@bib0040]). The second most prevalent combination was RSV and HRV (24%). This combination has been reported as the most common co-infection in other studies ([@bib0060]; [@bib0220]; [@bib0225]; [@bib0235]). The high incidence of RSV and HRV co-infection can be explained by the substantial overlapping of the monthly distribution observed for these viruses during the study period ([@bib0225]). Quantification of the viruses in the samples may help to better understand the etiological role of each virus ([@bib0245]). A study of the clinical features is required to clarify the disease severity in mixed infections ([@bib0225]).

5. Conclusions {#sec0085}
==============

A wide range of respiratory viruses were detected in this study facilitated by molecular diagnostic methods. Molecular methods increased the detection rate by up to 27% compared with conventional methods. The high detection rate of HRV confirmed its association with severe LRTI and hospitalization. Our study also demonstrated that HMPV and HBoV can be important causes of hospitalization of Malaysian children. Yearly variations in the incidence of respiratory viruses may influence their association with ALRTIs and therefore our six months study should be considered as a snapshot of viral ALRTIs in pediatric inpatients.
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[^1]: Numbers in parentheses, percentages.

[^2]: ^a^including DFA and SVC and conventional cell culture; NA: not available; ^b^ No of positive samples detected by conventional but not by molecular assay; ^c^No of positive samples detected by molecular but not immunological assay;^d^ McNemar test; ^e^ Paired-samples t-test.
